Literature DB >> 28877559

An instrumented timed up and go in facioscapulohumeral muscular dystrophy.

Jessie Huisinga1, Adam Bruetsch1, Ayla Mccalley2, Melissa Currence2, Laura Herbelin2, Omar Jawdat2, Mamatha Pasnoor2, Mazen Dimachkie2, Richard Barohn2, Jeffrey Statland2.   

Abstract

INTRODUCTION: Instrumenting timed functional motor tasks may reveal a continuum of motor disability that predicts future motor dysfunction.
METHODS: We performed a prospective study of the instrumented timed up and go (iTUG) test in genetically confirmed facioscapulohumeral muscular dystrophy (FSHD) participants using a commercially available system of wireless motion sensors. Patients returned within 2 weeks to determine test-retest reliability. Gait parameters in FSHD participants were compared with a normative database, FSHD clinical severity score, manual muscle testing, and patient-reported functional disability.
RESULTS: Gait parameters in FSHD participants were significantly (P < 0.05) altered compared with normative values, and reliability was excellent (intraclass correlation coefficient 0.84-0.99). Stride velocity and trunk sagittal range of motion had moderate to strong correlations to other FSHD disease measures. DISCUSSION: The iTUG was reliable, abnormal in FSHD, and could distinguish between participants with differing disease severities. Instrumenting timed functional tasks may prove to be useful in FSHD clinical trials. Muscle Nerve 57: 503-506, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  PROMIS PF; facioscapulohumeral muscular dystrophy; iTUG; test-retest reliability; timed up and go test

Mesh:

Year:  2017        PMID: 28877559      PMCID: PMC6631361          DOI: 10.1002/mus.25955

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Authors: 
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

2.  iTUG, a sensitive and reliable measure of mobility.

Authors:  Arash Salarian; Fay B Horak; Cris Zampieri; Patricia Carlson-Kuhta; John G Nutt; Kamiar Aminian
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2010-04-12       Impact factor: 3.802

3.  Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: Pattern refinement and implications for clinical trials.

Authors:  Giorgio Tasca; Mauro Monforte; Pierfrancesco Ottaviani; Marco Pelliccioni; Roberto Frusciante; Francesco Laschena; Enzo Ricci
Journal:  Ann Neurol       Date:  2016-04-04       Impact factor: 10.422

4.  A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.

Authors:  Costanza Lamperti; Greta Fabbri; Liliana Vercelli; Roberto D'Amico; Roberto Frusciante; Emanuela Bonifazi; Chiara Fiorillo; Carlo Borsato; Michelangelo Cao; Maura Servida; Francesca Greco; Rita Di Leo; Leda Volpi; Claudia Manzoli; Paola Cudia; Ebe Pastorello; Leopoldo Ricciardi; Gabriele Siciliano; Giuliana Galluzzi; Carmelo Rodolico; Lucio Santoro; Giuliano Tomelleri; Corrado Angelini; Enzo Ricci; Laura Palmucci; Maurizio Moggio; Rossella Tupler
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

5.  Definitive molecular diagnosis of facioscapulohumeral dystrophy.

Authors:  R W Orrell; R Tawil; J Forrester; J T Kissel; J R Mendell; D A Figlewicz
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

6.  Risk of functional impairment in Facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Muscle Nerve       Date:  2014-02-10       Impact factor: 3.217

7.  Mobility assessment of patients with facioscapulohumeral dystrophy.

Authors:  M Iosa; C Mazzà; R Frusciante; M Zok; I Aprile; E Ricci; A Cappozzo
Journal:  Clin Biomech (Bristol, Avon)       Date:  2007-09-11       Impact factor: 2.063

8.  The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency.

Authors:  Matthias Rose; Jakob B Bjorner; Barbara Gandek; Bonnie Bruce; James F Fries; John E Ware
Journal:  J Clin Epidemiol       Date:  2014-05       Impact factor: 6.437

9.  The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease.

Authors:  Cris Zampieri; Arash Salarian; Patricia Carlson-Kuhta; Kamiar Aminian; John G Nutt; Fay B Horak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-02       Impact factor: 10.154

10.  The timed "Up & Go": a test of basic functional mobility for frail elderly persons.

Authors:  D Podsiadlo; S Richardson
Journal:  J Am Geriatr Soc       Date:  1991-02       Impact factor: 5.562

  10 in total
  3 in total

Review 1.  Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials.

Authors:  Mehdi Ghasemi; Charles P Emerson; Lawrence J Hayward
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

2.  Spatio-temporal gait differences in facioscapulohumeral muscular dystrophy during single and dual task overground walking - A pilot study.

Authors:  Sushma Alphonsa; Ryan Wuebbles; Takako Jones; Phil Pavilionis; Nicholas Murray
Journal:  J Clin Transl Res       Date:  2022-03-19

3.  Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey M Statland; Craig Campbell; Urvi Desai; Chafic Karam; Jordi Díaz-Manera; Jeffrey T Guptill; Lawrence Korngut; Angela Genge; Rabi N Tawil; Lauren Elman; Nanette C Joyce; Kathryn R Wagner; Georgios Manousakis; Anthony A Amato; Russell J Butterfield; Perry B Shieh; Matthew Wicklund; Josep Gamez; Cynthia Bodkin; Alan Pestronk; Conrad C Weihl; Juan J Vilchez-Padilla; Nicholas E Johnson; Katherine D Mathews; Barry Miller; Ashley Leneus; Marcie Fowler; Marc van de Rijn; Kenneth M Attie
Journal:  Muscle Nerve       Date:  2022-05-09       Impact factor: 3.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.